Quick Answer
ULTRALIFE CORP reported Cash and Equivalents of $14.39 million for fiscal year 2015.
ULTRALIFE CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2015 | $14.39M | -18.7% |
| 2014 | $17.71M | +10.2% |
| 2013 | $16.07M | +66.4% |
| 2012 | $9.66M | +81.5% |
| 2011 | $5.32M | +14.6% |
| 2010 | $4.64M | -23.8% |
| 2009 | $6.09M | +224.5% |
| 2008 | $1.88M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2016 | $6.65M | -54.4% | +113.1% |
| June 30, 2016 | $3.12M | -80.2% | +13.1% |
| March 31, 2016 | $2.76M | -86.3% | -80.8% |
| December 31, 2015 | $14.39M | -18.7% | -1.3% |
| September 30, 2015 | $14.59M | -6.3% | -7.6% |
| June 30, 2015 | $15.79M | -8.0% | -21.6% |
| March 31, 2015 | $20.13M | +7.4% | +13.7% |
| December 31, 2014 | $17.71M | +7.4% | +13.7% |
- ULTRALIFE CORP showed a decrease of -18.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2015 period, ULTRALIFE CORP’s cash and equivalents has grown by 666.4% (from $1.88 million to $14.39 million).
- The most recent figure is from ULTRALIFE CORP’s fiscal year 2015 report (Form 10-K), filed with the SEC on March 2, 2016.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: